Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-23

Clinical Trial Update: Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients

View source ↗

Summary

A clinical trial update examining Demodex density, immune response, and oxidative stress in rosacea patients; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul Training and Research Hospital | Conditions: Rosacea | Status: UNKNOWN